1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Western Europe Cancer Radiation Therapy Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Western Europe Cancer Radiation Therapy Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Western Europe Cancer Radiation Therapy Market Regional Analysis
6.2 Western Europe Cancer Radiation Therapy Market Revenue 2021-2031 (US$ Million)
6.3 Western Europe Cancer Radiation Therapy Market Forecast Analysis
7. Western Europe Cancer Radiation Therapy Market Analysis – by Type
7.1 External Beam Radiation Therapy
- 7.1.1 Overview
- 7.1.2 External Beam Radiation Therapy: Western Europe Cancer Radiation Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Internal Beam Radiation Therapy
- 7.2.1 Overview
- 7.2.2 Internal Beam Radiation Therapy: Western Europe Cancer Radiation Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8. Western Europe Cancer Radiation Therapy Market Analysis – by Cancer Type
8.1 Lung Cancer
- 8.1.1 Overview
- 8.1.2 Lung Cancer: Western Europe Cancer Radiation Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Breast Cancer
- 8.2.1 Overview
- 8.2.2 Breast Cancer: Western Europe Cancer Radiation Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Colorectal Cancer
- 8.3.1 Overview
- 8.3.2 Colorectal Cancer: Western Europe Cancer Radiation Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.4 Prostate Cancer
- 8.4.1 Overview
- 8.4.2 Prostate Cancer: Western Europe Cancer Radiation Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.5 Head & Neck Cancer
- 8.5.1 Overview
- 8.5.2 Head & Neck Cancer: Western Europe Cancer Radiation Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.6 Cervical Cancer
- 8.6.1 Overview
- 8.6.2 Cervical Cancer: Western Europe Cancer Radiation Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.7 Other Cancer Types
- 8.7.1 Overview
- 8.7.2 Other Cancer Types: Western Europe Cancer Radiation Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
9. Western Europe Cancer Radiation Therapy Market Analysis – by End User
9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Hospitals: Western Europe Cancer Radiation Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Specialty Clinics
- 9.2.1 Overview
- 9.2.2 Specialty Clinics: Western Europe Cancer Radiation Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.3 Ambulatory and Radiotherapy Centers
- 9.3.1 Overview
- 9.3.2 Ambulatory and Radiotherapy Centers: Western Europe Cancer Radiation Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.4 Academic and Research Institutes
- 9.4.1 Overview
- 9.4.2 Academic and Research Institutes: Western Europe Cancer Radiation Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
10. Western Europe Cancer Radiation Therapy Market – Western Europe Analysis
10.1 Overview
10.2 Western Europe
- 10.2.1 Western Europe Cancer Radiation Therapy Market Breakdown, by Key
Country, 2025 and 2031 (%)
- 10.2.1.1 Western Europe Cancer Radiation Therapy Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 Belgium:
Western Europe Cancer Radiation Therapy Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.1.1 Belgium: Western Europe Cancer Radiation Therapy Market Breakdown, by Type
- 10.2.1.1.2 Belgium: Western Europe Cancer Radiation Therapy Market Breakdown, by Cancer Type
- 10.2.1.1.3 Belgium: Western Europe Cancer Radiation Therapy Market Breakdown, by End User
- 10.2.1.2 Netherlands:
Western Europe Cancer Radiation Therapy Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.2.1 Netherlands: Western Europe Cancer Radiation Therapy Market Breakdown, by Type
- 10.2.1.2.2 Netherlands: Western Europe Cancer Radiation Therapy Market Breakdown, by Cancer Type
- 10.2.1.2.3 Netherlands: Western Europe Cancer Radiation Therapy Market Breakdown, by End User
- 10.2.1.3 Luxembourg:
Western Europe Cancer Radiation Therapy Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.3.1 Luxembourg: Western Europe Cancer Radiation Therapy Market Breakdown, by Type
- 10.2.1.3.2 Luxembourg: Western Europe Cancer Radiation Therapy Market Breakdown, by Cancer Type
- 10.2.1.3.3 Luxembourg: Western Europe Cancer Radiation Therapy Market Breakdown, by End User
- 10.2.1.4 Germany:
Western Europe Cancer Radiation Therapy Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.4.1 Germany: Western Europe Cancer Radiation Therapy Market Breakdown, by Type
- 10.2.1.4.2 Germany: Western Europe Cancer Radiation Therapy Market Breakdown, by Cancer Type
- 10.2.1.4.3 Germany: Western Europe Cancer Radiation Therapy Market Breakdown, by End User
- 10.2.1.5 France:
Western Europe Cancer Radiation Therapy Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.5.1 France: Western Europe Cancer Radiation Therapy Market Breakdown, by Type
- 10.2.1.5.2 France: Western Europe Cancer Radiation Therapy Market Breakdown, by Cancer Type
- 10.2.1.5.3 France: Western Europe Cancer Radiation Therapy Market Breakdown, by End User
- 10.2.1.6 Italy:
Western Europe Cancer Radiation Therapy Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.6.1 Italy: Western Europe Cancer Radiation Therapy Market Breakdown, by Type
- 10.2.1.6.2 Italy: Western Europe Cancer Radiation Therapy Market Breakdown, by Cancer Type
- 10.2.1.6.3 Italy: Western Europe Cancer Radiation Therapy Market Breakdown, by End User
- 10.2.1.7 Spain:
Western Europe Cancer Radiation Therapy Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.7.1 Spain: Western Europe Cancer Radiation Therapy Market Breakdown, by Type
- 10.2.1.7.2 Spain: Western Europe Cancer Radiation Therapy Market Breakdown, by Cancer Type
- 10.2.1.7.3 Spain: Western Europe Cancer Radiation Therapy Market Breakdown, by End User
- 10.2.1.8 Switzerland:
Western Europe Cancer Radiation Therapy Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.8.1 Switzerland: Western Europe Cancer Radiation Therapy Market Breakdown, by Type
- 10.2.1.8.2 Switzerland: Western Europe Cancer Radiation Therapy Market Breakdown, by Cancer Type
- 10.2.1.8.3 Switzerland: Western Europe Cancer Radiation Therapy Market Breakdown, by End User
- 10.2.1.9 Sweden:
Western Europe Cancer Radiation Therapy Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.9.1 Sweden: Western Europe Cancer Radiation Therapy Market Breakdown, by Type
- 10.2.1.9.2 Sweden: Western Europe Cancer Radiation Therapy Market Breakdown, by Cancer Type
- 10.2.1.9.3 Sweden: Western Europe Cancer Radiation Therapy Market Breakdown, by End User
- 10.2.1.10 Austria:
Western Europe Cancer Radiation Therapy Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.10.1 Austria: Western Europe Cancer Radiation Therapy Market Breakdown, by Type
- 10.2.1.10.2 Austria: Western Europe Cancer Radiation Therapy Market Breakdown, by Cancer Type
- 10.2.1.10.3 Austria: Western Europe Cancer Radiation Therapy Market Breakdown, by End User
- 10.2.1.11 United Kingdom:
Western Europe Cancer Radiation Therapy Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.11.1 United Kingdom: Western Europe Cancer Radiation Therapy Market Breakdown, by Type
- 10.2.1.11.2 United Kingdom: Western Europe Cancer Radiation Therapy Market Breakdown, by Cancer Type
- 10.2.1.11.3 United Kingdom: Western Europe Cancer Radiation Therapy Market Breakdown, by End User
- 10.2.1.12 Denmark:
Western Europe Cancer Radiation Therapy Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.12.1 Denmark: Western Europe Cancer Radiation Therapy Market Breakdown, by Type
- 10.2.1.12.2 Denmark: Western Europe Cancer Radiation Therapy Market Breakdown, by Cancer Type
- 10.2.1.12.3 Denmark: Western Europe Cancer Radiation Therapy Market Breakdown, by End User
- 10.2.1.13 Portugal:
Western Europe Cancer Radiation Therapy Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.13.1 Portugal: Western Europe Cancer Radiation Therapy Market Breakdown, by Type
- 10.2.1.13.2 Portugal: Western Europe Cancer Radiation Therapy Market Breakdown, by Cancer Type
- 10.2.1.13.3 Portugal: Western Europe Cancer Radiation Therapy Market Breakdown, by End User
- 10.2.1.14 Norway:
Western Europe Cancer Radiation Therapy Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.14.1 Norway: Western Europe Cancer Radiation Therapy Market Breakdown, by Type
- 10.2.1.14.2 Norway: Western Europe Cancer Radiation Therapy Market Breakdown, by Cancer Type
- 10.2.1.14.3 Norway: Western Europe Cancer Radiation Therapy Market Breakdown, by End User
- 10.2.1.15 Finland:
Western Europe Cancer Radiation Therapy Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.15.1 Finland: Western Europe Cancer Radiation Therapy Market Breakdown, by Type
- 10.2.1.15.2 Finland: Western Europe Cancer Radiation Therapy Market Breakdown, by Cancer Type
- 10.2.1.15.3 Finland: Western Europe Cancer Radiation Therapy Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Siemens Healthineers
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Accuray Incorporated
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Elekta
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Brainlab AG
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 RefleXion
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Hitachi Ltd
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 IBA Worldwide
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 GT Medical Technologies, Inc.
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Mevion Medical Systems
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Theragenics Corporation
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations